The Role of miR-212 and iNOS in Alcohol-Induced Intestinal Barrier Dysfunction and Steatohepatitis

Alcoholism: Clinical and Experimental Research

Volumn 39, Issue 9, 2015, Pages 1632-1641

  Tang, Yueming ^a   Zhang, Lijuan ^a   Forsyth, Christopher B ^a   Shaikh, Maliha ^a   Song, Shiwen ^a   Keshavarzian, Ali ^a  

^a RUSH UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

Alcoholic Liver Disease; Inducible Nitric Oxide Synthase; Intestinal Permeability; MicroRNA 212; Zonula Occludens 1

Indexed keywords

INDUCIBLE NITRIC OXIDE SYNTHASE; MICRORNA; MICRORNA 122; MICRORNA 212; PROTEIN ZO1; UNCLASSIFIED DRUG; ALCOHOL; MIRN122 MICRORNA, MOUSE; NOS2 PROTEIN, MOUSE;

ALCOHOL CONSUMPTION; ALCOHOL INDUCED INTESTINAL BARRIER DYSFUNCTION; ALCOHOL LIVER DISEASE; ALCOHOLISM; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CACO 2 CELL LINE; CELL MEMBRANE PERMEABILITY; CONTROLLED STUDY; DOWN REGULATION; ELECTRIC RESISTANCE; ENTEROPATHY; IN VITRO STUDY; IN VIVO STUDY; INTESTINE EPITHELIUM CELL; INTESTINE MUCOSA PERMEABILITY; LIVER CELL DAMAGE; MOUSE; NONHUMAN; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROTEIN EXPRESSION; REAL TIME POLYMERASE CHAIN REACTION; UPREGULATION; ADVERSE EFFECTS; ANIMAL; C57BL MOUSE; CACO-2 CELL LINE; CHEMICALLY INDUCED; DRINKING BEHAVIOR; DRUG EFFECTS; FATTY LIVER; HUMAN; INTESTINE MUCOSA; KNOCKOUT MOUSE; METABOLISM; PATHOLOGY; PERMEABILITY; PHYSIOLOGY;

ALCOHOL DRINKING; ANIMALS; CACO-2 CELLS; ETHANOL; FATTY LIVER; HUMANS; INTESTINAL MUCOSA; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; MICRORNAS; NITRIC OXIDE SYNTHASE TYPE II; PERMEABILITY;

EID: 84941168421     PISSN: 01456008     EISSN: 15300277     Source Type: Journal    
DOI: 10.1111/acer.12813     Document Type: Article

References (52)

1. Ambros V (2004) The functions of animal microRNAs. Nature 431:350-355.
2. Banan A, Fields JZ, Decker H, Zhang Y, Keshavarzian A (2000a) Nitric oxide and its metabolites mediate ethanol-induced microtubule disruption and intestinal barrier dysfunction. J Pharmacol Exp Ther 294:997-1008.
3. Banan A, Keshavarzian A, Zhang L, Shaikh M, Forsyth CB, Tang Y, Fields JZ (2007) NF-kappaB activation as a key mechanism in ethanol-induced disruption of the F-actin cytoskeleton and monolayer barrier integrity in intestinal epithelium. Alcohol 41:447-460.
4. Banan A, Zhang Y, Losurdo J, Keshavarzian A (2000b) Carbonylation and disassembly of the F-actin cytoskeleton in oxidant induced barrier dysfunction and its prevention by epidermal growth factor and transforming growth factor alpha in a human colonic cell line. Gut 46:830-837.
5. Beck PL, Li Y, Wong J, Chen CW, Keenan CM, Sharkey KA, McCafferty DM (2007) Inducible nitric oxide synthase from bone marrow-derived cells plays a critical role in regulating colonic inflammation. Gastroenterology 132:1778-1790.
6. Bode C, Bode JC (2005) Activation of the innate immune system and alcoholic liver disease: effects of ethanol per se or enhanced intestinal translocation of bacterial toxins induced by ethanol? Alcohol Clin Exp Res 29(11 Suppl):166S-171S.
7. Brunt EM, Tiniakos DG (2010) Histopathology of nonalcoholic fatty liver disease. World J Gastroenterol 16:5286-5296.
8. Burbige EJ, Lewis DR Jr, Halsted CH (1984) Alcohol and the gastrointestinal tract. Med Clin North Am 68:77-89.
9. Carthew RW (2006) Gene regulation by microRNAs. Curr Opin Genet Dev 16:203-208.
10. Clayburgh DR, Shen L, Turner JR (2004) A porous defense: the leaky epithelial barrier in intestinal disease. Lab Invest 84:282-291.
11. Czech MP (2006) MicroRNAs as therapeutic targets. N Engl J Med 354:1194-1195.
12. Deng XS, Deitrich RA (2007) Ethanol metabolism and effects: nitric oxide and its interaction. Curr Clin Pharmacol 2:145-153.
13. Elmen J, Lindow M, Schutz S, Lawrence M, Petri A, Obad S, Lindholm M, Hedtjarn M, Hansen HF, Berger U, Gullans S, Kearney P, Sarnow P, Straarup EM, Kauppinen S (2008) LNA-mediated microRNA silencing in non-human primates. Nature 452:896-899.
14. Forsyth CB, Banan A, Farhadi A, Fields JZ, Tang Y, Shaikh M, Zhang LJ, Engen PA, Keshavarzian A (2007) Regulation of oxidant-induced intestinal permeability by metalloprotease-dependent epidermal growth factor receptor signaling. J Pharmacol Exp Ther 321:84-97.
15. Forsyth CB, Farhadi A, Jakate SM, Tang Y, Shaikh M, Keshavarzian A (2009) Lactobacillus GG treatment ameliorates alcohol-induced intestinal oxidative stress, gut leakiness, and liver injury in a rat model of alcoholic steatohepatitis. Alcohol 43:163-172.
16. Forsyth CB, Tang Y, Shaikh M, Zhang L, Keshavarzian A (2011) Role of snail activation in alcohol-induced iNOS-mediated disruption of intestinal epithelial cell permeability. Alcohol Clin Exp Res 35:1635-1643.
17. Galambos J (1973) Alcoholic hepatitis: its therapy and prognosis. Prog Liver Dis 4:567-588.
18. Grant BF, Dufour MC, Harford TC (1988) Epidemiology of alcoholic liver disease. Semin Liver Dis 8:12-25.
19. Hollander D (1992) The intestinal permeability barrier. A hypothesis as to its regulation and involvement in Crohn's disease. Scand J Gastroenterol 27:721-726.
20. Hollander JA, Im HI, Amelio AL, Kocerha J, Bali P, Lu Q, Willoughby D, Wahlestedt C, Conkright MD, Kenny PJ (2010) Striatal microRNA controls cocaine intake through CREB signalling. Nature 466:197-202.
21. Jaeschke H, Gores GJ, Cederbaum AI, Hinson JA, Pessayre D, Lemasters JJ (2002) Mechanisms of hepatotoxicity. Toxicol Sci 65:166-176.
22. Keshavarzian A, Choudhary S, Holmes EW, Yong S, Banan A, Jakate S, Fields JZ (2001) Preventing gut leakiness by oats supplementation ameliorates alcohol-induced liver damage in rats. J Pharmacol Exp Ther 299:442-448.
23. Keshavarzian A, Farhadi A, Forsyth CB, Rangan J, Jakate S, Shaikh M, Banan A, Fields JZ (2009) Evidence that chronic alcohol exposure promotes intestinal oxidative stress, intestinal hyperpermeability and endotoxemia prior to development of alcoholic steatohepatitis in rats. J Hepatol 50:538-547.
24. Keshavarzian A, Fields J (2003) Alcoholic liver disease: is it an "extraintestinal" complication of alcohol-induced intestinal injury? J Lab Clin Med 142:285-287.
25. Keshavarzian A, Holmes EW, Patel M, Iber F, Fields JZ, Pethkar S (1999) Leaky gut in alcoholic cirrhosis: a possible mechanism for alcohol-induced liver damage. Am J Gastroenterol 94:200-207.
26. Kiriakidou M, Nelson PT, Kouranov A, Fitziev P, Bouyioukos C, Mourelatos Z, Hatzigeorgiou A (2004) A combined computational-experimental approach predicts human microRNA targets. Genes Dev 18:1165-1178.
27. Kleiner DE, Brunt EM, Van Natta M, Behling C, Contos MJ, Cummings OW, Ferrell LD, Liu YC, Torbenson MS, Unalp-Arida A, Yeh M, McCullough AJ, Sanyal AJ (2005) Design and validation of a histological scoring system for nonalcoholic fatty liver disease. Hepatology 41:1313-1321.
28. Krek A, Grun D, Poy MN, Wolf R, Rosenberg L, Epstein EJ, MacMenamin P, da Piedade I, Gunsalus KC, Stoffel M, Rajewsky N (2005) Combinatorial microRNA target predictions. Nat Genet 37:495-500.
29. Krieglstein CF, Anthoni C, Cerwinka WH, Stokes KY, Russell J, Grisham MB, Granger DN (2007) Role of blood- and tissue-associated inducible nitric-oxide synthase in colonic inflammation. Am J Pathol 170:490-496.
30. Krutzfeldt J, Kuwajima S, Braich R, Rajeev KG, Pena J, Tuschl T, Manoharan M, Stoffel M (2007) Specificity, duplex degradation and subcellular localization of antagomirs. Nucleic Acids Res 35:2885-2892.
31. Lewis BP, Shih IH, Jones-Rhoades MW, Bartel DP, Burge CB (2003) Prediction of mammalian microRNA targets. Cell 115:787-798.
32. Lippai D, Bala S, Csak T, Kurt-Jones EA, Szabo G (2013) Chronic alcohol-induced microRNA-155 contributes to neuroinflammation in a TLR4-dependent manner in mice. PLoS ONE 8:e70945.
33. Madara JL (1990) Warner-Lambert/Parke-Davis Award lecture. Pathobiology of the intestinal epithelial barrier. Am J Pathol 137:1273-1281.
34. Maher JJ (2002a) Alcoholic steatosis and steatohepatitis. Semin Gastrointest Dis 13:31-39.
35. Maher JJ (2002b) Treatment of alcoholic hepatitis. J Gastroenterol Hepatol 17:448-455.
36. Mathews S, Xu M, Wang H, Bertola A, Gao B (2014) Animal models of alcohol-induced liver disease: pathophysiology, translational relevance and challenges. Am J Physiol Gastrointest Liver Physiol 306:G819-G823.
37. Miranda RC, Pietrzykowski AZ, Tang Y, Sathyan P, Mayfield D, Keshavarzian A, Sampson W, Hereld D (2010) MicroRNAs: master regulators of ethanol abuse and toxicity? Alcohol Clin Exp Res 34:575-587.
38. O'Connor PG, Schottenfeld RS (1998) Patients with alcohol problems. N Engl J Med 338:592-602.
39. Prins SA, Przybycien-Szymanska MM, Rao YS, Pak TR (2014) Long-term effects of peripubertal binge EtOH exposure on hippocampal microRNA expression in the rat. PLoS ONE 9:e83166.
40. Rajewsky N (2006) microRNA target predictions in animals. Nat Genet 38(Suppl):S8-S13.
41. Sawada N, Murata M, Kikuchi K, Osanai M, Tobioka H, Kojima T, Chiba H (2003) Tight junctions and human diseases. Med Electron Microsc 36:147-156.
42. Shukla SD, Lim RW (2013) Epigenetic effects of ethanol on the liver and gastrointestinal system. Alcohol Res 35:47-55.
43. Shukla U, Tumma N, Gratsch T, Dombkowski A, Novak RF (2013) Insights into insulin-mediated regulation of CYP2E1: miR-132/-212 targeting of CYP2E1 and role of phosphatidylinositol 3-kinase, Akt (protein kinase B), mammalian target of rapamycin signaling in regulating miR-132/-212 and miR-122/-181a expression in primary cultured rat hepatocytes. Drug Metab Dispos 41:1769-1777.
44. Soares-Simi SL, Pastrello DM, Ferreira ZS, Yonamine M, Marcourakis T, Scavone C, Camarini R (2013) Changes in CREB activation in the prefrontal cortex and hippocampus blunt ethanol-induced behavioral sensitization in adolescent mice. Front Integr Neurosci 7:94.
45. Summa KC, Voigt RM, Forsyth CB, Shaikh M, Cavanaugh K, Tang Y, Vitaterna MH, Song S, Turek FW, Keshavarzian A (2013) Disruption of the circadian clock in mice increases intestinal permeability and promotes alcohol-induced hepatic pathology and inflammation. PLoS ONE 8:e67102.
46. Taganov KD, Boldin MP, Chang KJ, Baltimore D (2006) NF-kappaB-dependent induction of microRNA miR-146, an inhibitor targeted to signaling proteins of innate immune responses. Proc Natl Acad Sci USA 103:12481-12486.
47. Tang Y, Banan A, Forsyth CB, Fields JZ, Lau CK, Zhang LJ, Keshavarzian A (2008) Effect of alcohol on miR-212 expression in intestinal epithelial cells and its potential role in alcoholic liver disease. Alcohol Clin Exp Res 32:355-364.
48. Tang Y, Forsyth CB, Banan A, Fields JZ, Keshavarzian A (2009a) Oats supplementation prevents alcohol-induced gut leakiness in rats by preventing alcohol-induced oxidative tissue damage. J Pharmacol Exp Ther 329:952-958.
49. Tang Y, Forsyth CB, Farhadi A, Rangan J, Jakate S, Shaikh M, Banan A, Fields JZ, Keshavarzian A (2009b) Nitric oxide-mediated intestinal injury is required for alcohol-induced gut leakiness and liver damage. Alcohol Clin Exp Res 33:1220-1230.
50. Torres AG, Fabani MM, Vigorito E, Gait MJ (2011) MicroRNA fate upon targeting with anti-miRNA oligonucleotides as revealed by an improved Northern-blot-based method for miRNA detection. RNA 17:933-943.
51. Unno N, Wang H, Menconi MJ, Tytgat SH, Larkin V, Smith M, Morin MJ, Chavez A, Hodin RA, Fink MP (1997) Inhibition of inducible nitric oxide synthase ameliorates endotoxin-induced gut mucosal barrier dysfunction in rats. Gastroenterology 113:1246-1257.
52. Wong HK, Veremeyko T, Patel N, Lemere CA, Walsh DM, Esau C, Vanderburg C, Krichevsky AM (2013) De-repression of FOXO3a death axis by microRNA-132 and -212 causes neuronal apoptosis in Alzheimer's disease. Hum Mol Genet 22:3077-3092.